AP NEWS
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Globe Newswire
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation.

iCAD to Present Corporate Overview at the 31st Annual ROTH Conference

March 14, 2019

NASHUA, N.H., March 14, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chief Executive Officer, and Stacey Stevens, Chief Strategy & Commercial Officer, will be meeting with investors in a one-on-one format at the 31st Annual ROTH Conference, being held March 17-19 in Laguna Niguel, California. A pre-recorded webcast of the corporate overview will be available at http://wsw.com/webcast/roth33/icad/.

About iCAD, Inc. Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:

Investor Relations:LifeSci AdvisorsJeremy Feffer(212) 915-2568 jeremy@lifesciadvisors.com

or:

Media Inquiries:ARPR, on behalf of iCAD, Inc.Paul Barren(855) 300-8209 paul@arpr.com